Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • BPA exposure linked to autism spectrum disorder, study reports

  • BPA exposure linked to autism spectrum disorder

  • One step closer to defeating Alzheimer's disease

  • Cerebral blood flow as a possible marker for concussion outcomes

  • Survey of teen dating violence among US high school students

  • Minors easily able to purchase electronic cigarettes online

  • Scientists crack piece of neural code for learning, memory

  • Low sugar uptake in brain appears to exacerbate Alzheimer's disease

  • New assessment tool can predict successful teachers

  • Heart valve repair significantly improves emotional wellbeing in patients with mitral regurgitation

  •